RyboDyn, Inc. Announces Discovery of a Cryptic Human Proteome and $4M Pre-Seed Financing
Dark genome biotech company RyboDyn closes pre-seed fundraise from leading global investors to advance cancer immunotherapy SAN DIEGO, Jan. 9, 2025 /PRNewswire/ — RyboDyn, Inc., has announced the discovery of a new proteome and the successful closing of…